Safety and efficacy of the 0 h/3 h protocol for rapid rule out of myocardial infarction

详细信息    查看全文

• 作者：Karin Wildi ; MD^a ; ^b ; ^c ; ¹ ; Berit Nelles ; MD^a ; ^b ; ¹ ; Raphael Twerenbold ; MD^a ; Maria Rubini Gimé ; nez ; MD^a ; ^b ; ^d ; Tobias Reichlin ; MD^a ; Hé ; lè ; ne Singeisen ; MD^a ; Sophie Druey ; MD^a ; Philip Haaf ; MD^a ; Zaid Sabti ; MD^a ; Petra Hillinger ; MD^a ; Cedric Jaeger ; MD^a ; Isabel Campodarve ; MD^d ; Philip Kreutzinger ; MD^a ; Christian Puelacher ; MD^a ; Zoraida Moreno Weidmann ; MD^a ; Mathias Gugala ; MD^a ; Gilles Pretre ; MD^a ; Stephanie Doerflinger ; MS^a ; Max Wagener ; MD^a ; Fabio Stallone ; MD^a ; Michael Freese ; RN^a ; Claudia Stelzig ; MS^a ; Katharina Rentsch ; PhD^e ; Stefano Bassetti ; MD^f ; Roland Bingisser ; MD^g ; Stefan Osswald ; MD^a ; Christian Mueller ; MD^a ; ^{christian.mueller@usb.ch" class="auth_mail" title="E-mail the corresponding author}
• 刊名：American Heart Journal
• 出版年：2016
• 出版时间：November 2016
• 年：2016
• 卷：181
• 期：Complete
• 页码：16-25
• 全文大小：1095 K

文摘

The early and accurate diagnosis of acute myocardial infarction (AMI) is an important medical and economic challenge. We aimed to prospectively evaluate the performance of the new European Society of Cardiology rapid 0-hour/3-hour (0 h/3 h) rule out protocol for AMI.

Methods

We enrolled 2,727 consecutive patients presenting with suspected AMI without persistent ST-segment elevation to the emergency department in a prospective international multicenter study. The final diagnosis was adjudicated by 2 independent cardiologists. The performance of the 0 h/3 h rule out protocol was evaluated using 4 high-sensitivity (primary analysis) and 3 sensitive cardiac troponin (cTn) assays.

Results

Acute myocardial infarction was the final diagnosis in 473 patients (17.3%). Using the 4 high-sensitivity cTn assays, the 0-hour rule out protocol correctly ruled out 99.8% (95% [confidence interval] CI, 98.7%-100%), 99.6% (95% CI, 98.5%-99.9%), 100% (95% CI, 97.9%-100%), and 100% (95% CI, 98.0%-100%) of late presenters (>6 h from chest pain onset). The 3-hour rule out protocol correctly ruled out 99.9% (95% CI, 99.1%-100%), 99.5% (95% CI, 98.3%-99.9%), 100% (95% CI, 98.1%-100%), and 100% (95% CI, 98.2%-100%) of early presenters (<6 h from chest pain onset). Using the 3 sensitive cTn assays, the 0-hour rule out protocol correctly ruled out 99.6% (95% CI, 98.6%-99.9%), 99.0% (95% CI, 96.9%-99.7%), and 99.1% (95% CI, 97.2%-99.8%) of late presenters; and the 3-hour rule out protocol correctly ruled out 99.4% (95% CI, 98.3%-99.8%), 99.2% (95% CI, 97.3%-99.8%), and 99.0% (95% CI, 97.2%-99.7%) of early presenters. Overall, the 0 h/3 h rule out protocol assigned 40% to 60% of patients to rule out. None of the patients assigned rule out died during 3-months follow-up.

Conclusions

The 0 h/3 h rule out protocol seems to allow the accurate rule out of AMI using both high-sensitivity and sensitive cTn measurements in conjunction with clinical assessment. Additional studies are warranted for external validation.